Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Academic Emergency Medicine

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1553-2712.1996.TB03367.XPMID 8959162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma nitrate concentrations in neutropenic and non‐neutropenic patients with suspected septicaemia

  1995cited by this paper
• Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs.

  1995cited by this paper
• The metabolites of nitric oxide in sickle‐cell disease

  1995cited by this paper
• Are serum concentrations of nitric oxide metabolites useful for predicting the clinical outcome of severe ulcerative colitis?

  1995cited by this paper
• Microvascular changes during cerebral ischemia and reperfusion.

  1994cited by this paper
• SERUM LEVELS OF END PRODUCTS OF NITRIC OXIDE SYNTHESIS CORRELATE POSITIVELY WITH TUMOR NECROSIS FACTOR α AND NEGATIVELY WITH BODY TEMPERATURE IN PATIENTS WITH POSTOPERATIVE ABDOMINAL SEPSIS

  1994cited by this paper
• Microvascular changes during cerebral ischemia and reperfusion.

  1994cited by this paper
• Effect of topical administration of l‐arginine on formalin‐induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation

  1994cited by this paper
• Increased nitric oxide production in heart failure.

  1994cited by this paper
• Nitric oxide evokes pain in humans on intracutaneous injection.

  1994cited by this paper
• Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.

  1993cited by this paper
• Evidence of increased nitric oxide production in patients with the sepsis syndrome.

  1993cited by this paper
• Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine.

  1992cited by this paper
• Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.

  1992cited by this paper
• EDRF plays central role in collateral flow after arterial occlusion in rabbit ear.

  1992cited by this paper
• Role of endothelium-derived nitric oxide in myocardial reactive hyperemia.

  1992cited by this paper
• Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion

  1991cited by this paper
• The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone

  1990cited by this paper
• Role of nitric oxide in maintaining vascular integrity in endotoxin‐induced acute intestinal damage in the rat

  1990cited by this paper
• Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection.

  1989cited by this paper
• Nitric oxide: a cytotoxic activated macrophage effector molecule.

  1988cited by this paper
• Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.

  1987cited by this paper
• Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

  1987cited by this paper
• Mechanism of action of some inhibitors of endothelium-derived relaxing factor.

  1986cited by this paper
• Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

  1986cited by this paper
• Eicosonoid metabolism and beta-adrenergic mechanisms in coronary arterial smooth muscle: potential compartmentation of cAMP.

  1986cited by this paper
• Fluctuating deformability of oxygenated sickle erythrocytes in the asymptomatic state and in painful crisis

  1985cited by this paper
• Advances continue in sickle cell disease.

  1982cited by this paper
• Nitrate biosynthesis in man.

  1981cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• The sickle cell diseases. Clinical manifestations including the "sickle crisis".

  1974cited by this paper

• Arginine Therapy for Pain in Sickle Cell Disease: A Phase‐2 Randomized, Placebo‐Controlled Trial

  2025cites this paper
• Impact of Imatinib on reducing the painful crisis in patients with sickle cell disease

  2023cites this paper
• Menstrual Characteristics of Sickle Cell Disease Patients Seen at a Tertiary Institution in North Western Nigeria

  2021cites this paper
• Double-Blind Clinical Trial of Arginine Supplementation in the Treatment of Adult Patients with Sickle Cell Anaemia

  2019cites this paper
• Acute Vaso-Occlusive Pain is Temporally Associated with the Onset of Menstruation in Women with Sickle Cell Disease

  2019cites this paper
• Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana

  2018cites this paper
• Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis

  2017cites this paper
• The Defective Arginine-Nitric Oxide Pathway in Sickle Cell Disease

  2017cites this paper
• l-Arginine Therapy in Sickle Cell Disease

  2017cites this paper
• Simvastatin reduces vaso‐occlusive pain in sickle cell anaemia: a pilot efficacy trial

  2017cites this paper
• The role of the arginine metabolome in pain: implications for sickle cell disease

  2016cites this paper
• Overactive bladder in adults with sickle cell disease

  2016cites this paper
• Serum Magnesium Levels in Ghanaian Sickle Cell Disease Patients

  2015cites this paper
• Non-Invasive Characterization of Oxygen Transport in Sickle Cell Disease: A Pilot Study

  2015cites this paper
• Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy.

  2014cites this paper
• Association of Endothelial Nitric Oxide Synthase (Enos) Gene Polymorphism with Complications of Hbss in Ghanaian Sickle Cell Disease Patients

  2014cites this paper
• Molecular mechanisms underlying synergistic adhesion of sickle red blood cells by hypoxia and low nitric oxide bioavailability.

  2014cites this paper
• Endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease patients in India

  2013cites this paper
• Nitric oxide in gingival crevicular fluid and nitric oxide synthase expression in the gingiva of patients with sickle cell disease.

  2011cites this paper
• Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.

  2011cites this paper
• The effect of sildenafil on the elasticity of erythrocytes in homozygous sickle cell disease.

  2011cites this paper
• Nitrite and Nitrate in Ischemia–Reperfusion Injury

  2011cites this paper
• Effect of Oral Arginine Supplementation on Exhaled Nitric Oxide Concentration in Sickle Cell Anemia and Acute Chest Syndrome

  2010cites this paper
• Oxidative stress status, clinical outcome, and β‐globin gene cluster haplotypes in pediatric patients with sickle cell disease

  2010cites this paper
• Pathophysiologic considerations for the interactions between obstructive sleep apnea and sickle hemoglobinopathies.

  2009cites this paper
• Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

  2008cites this paper
• Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia

  2008cites this paper
• SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES

  2007cites this paper
• Pathophysiology and therapy for haemoglobinopathies; Part I: sickle cell disease

  2006cites this paper
• Inhaled nitric oxide for treatment of sickle cell stroke.

  2006cites this paper
• Inhaled Nitric Oxide for Treatment of Sickle Cell Stroke

  2006cites this paper
• New Strategies for the Treatment of Pulmonary Hypertension in Sickle Cell Disease

  2006cites this paper
• Sickle Cell Disease

  2006cites this paper
• Impaired vasodilation by red blood cells in sickle cell disease.

  2005cites this paper
• Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients

  2004influential citation
• Do we kNOw how HSP90 and eNOS mediate lung injury in sickle cell disease?

  2004cites this paper
• Established and experimental treatments for sickle cell disease.

  2004cites this paper
• Sickle Red Cell Microrheology and Sickle Blood Rheology

  2004cites this paper
• Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation.

  2003cites this paper
• Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

  2003cites this paper
• Exercise in sickle cell anemia: effect on inflammatory and vasoactive mediators.

  2001cites this paper
• Erythrocyte-active agents and treatment of sickle cell disease.

  2001cites this paper
• Acute chest syndrome of sickle cell disease: new light on an old problem

  2001cites this paper
• Inhaled Nitric Oxide Improves Survival Rates during Hypoxia in a Sickle Cell (SAD) Mouse Model

  2001cites this paper
• Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease

  2001cites this paper
• Red cell adhesion molecules, foetal haemoglobin and endothelial factors in sickle cell disorders

  2001cites this paper
• Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease

  2001cites this paper
• Nitric oxide therapy in sickle cell disease.

  2001cites this paper
• Nitric Oxide Metabolites in Sickle Cell Anemia Patients after Oral Administration of Hydroxyurea

  2000cites this paper
• Bench to bedside: nitric oxide in emergency medicine.

  2000cites this paper
• Nitric Oxide, Chronic Joint Inflammation, and Pain

  2000cites this paper
• Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis

  2000cites this paper
• Patterns of Arginine and Nitric Oxide in Patients With Sickle Cell Disease With Vaso-occlusive Crisis and Acute Chest Syndrome

  2000cites this paper
• Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease

  2000cites this paper
• Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium

  2000cites this paper
• The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment.

  1999cites this paper